U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06819501) titled 'Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs' on Jan. 21.
Brief Summary: The goal of this study was to explore the safety and efficacy of hyperbaric oxygen in the treatment of peripheral neuropathy due to paclitaxel analogues
Study Start Date: Feb. 05
Study Type: INTERVENTIONAL
Condition:
Breast Cancers
Intervention:
DEVICE: hyperbaric oxygenation treatment
Administration of 100% oxygen at a pressure of 2.0ATA once daily for 60-90 minutes for a total of 30-40 times.
BEHAVIORAL: routine care
Administration of pressurised ice gloves 30 minutes before, during, and 30 minutes after administering...